ticlopidine has been researched along with galantide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y; He, Y; Lai, X; Li, YG; Liu, X; Liu, Y; Sun, H; Yan, X; Zhang, EY; Zhang, L | 1 |
1 other study(ies) available for ticlopidine and galantide
| Article | Year |
|---|---|
Semi-mechanistic population pharmacokinetics analysis reveals distinct CYP2C19 dependency in the bioactivation of vicagrel and clopidogrel to active metabolite M15-2.
Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Galanin; Humans; Phenylacetates; Platelet Aggregation Inhibitors; Substance P; Thiophenes; Ticlopidine | 2022 |